RAJAVITHI HOSPITAL
🇹🇭Thailand
- Country
- 🇹🇭Thailand
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
126
Active:1
Completed:80
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:5
Phase 2:7
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (105 trials with phase data)• Click on a phase to view related trials
Not Applicable
51 (48.6%)Phase 4
22 (21.0%)Phase 3
19 (18.1%)Phase 2
7 (6.7%)Phase 1
5 (4.8%)Early Phase 1
1 (1.0%)Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye
Phase 4
- Conditions
- Dry Eye Disease (DED)Tear Break-Up TimeTear DisorderTear Film InsufficiencyTear Film HyperosmolarityCorneal StainingDry EyeHyaluronateHyaluronic AcidQuality of Life
- Interventions
- Drug: 0.28% Sodium Hyaluronate , preservative free eye dropsDrug: 0.18% Sodium Hyaluronate , preservative free eye drops
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Rajavithi Hospital
- Target Recruit Count
- 84
- Registration Number
- NCT06860659
- Locations
- 🇹🇭
Rajavithi Hospital, 2, Phayathai Road, Ratchathewi District, Bangkok, Thailand
Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy
Not Applicable
Recruiting
- Conditions
- Paclitaxel-induced Peripheral Neuropathy
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Rajavithi Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT06763575
- Locations
- 🇹🇭
Rajavithi Hospital, Medical Oncology Unit, Bangkok, Thailand
Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients
Phase 4
Not yet recruiting
- Conditions
- Non-Hodgkin's Lymphoma (NHL)Granulocyte Colony Stimulating FactorFebrile Neutropenia (FN)Myelosuppression Adult
- Interventions
- Drug: Early receiving G-CSF groupDrug: Late receiving G-CSF group
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Rajavithi Hospital
- Target Recruit Count
- 126
- Registration Number
- NCT06665737
- Locations
- 🇹🇭
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
🇹🇭Rajavithi Hospital, Bangkok, Thailand
🇹🇭Internal Medicine Unit, Pranongklao Hospital, Nontaburi, Thailand
Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Controlled Trial
Phase 2
- Conditions
- Cervical Intraepithelial NeoplasiaTrichloroacetic Acid
- Interventions
- Drug: 3% acetic acidDrug: 85%TCA topical application
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Rajavithi Hospital
- Target Recruit Count
- 44
- Registration Number
- NCT06525870
- Locations
- 🇹🇭
Rajavithi Hospital, Thailand, Bangkok, Thailand
Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Glycol Regimen
Not Applicable
Recruiting
- Conditions
- Bowel Preparation SolutionColonoscopy
- Interventions
- Drug: 4-Liter polyethylene glycol
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Rajavithi Hospital
- Target Recruit Count
- 360
- Registration Number
- NCT06436833
- Locations
- 🇹🇭
Rajavithi Hospital, Bangkok, Thailand
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
News
No news found